Moody Aldrich Partners LLC Uni Qure N.V. Transaction History

Moody Aldrich Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 07, 2020	SELL	$40.01 - $73.97 $1.81 Million - $3.34 Million	-45,160 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$37.13 - $74.62 $59,185 - $118,944	-1,594 Reduced 3.41%	45,160 $3.24 Million
Q3 2019 Nov 12, 2019	SELL	$39.36 - $76.8 $24,363 - $47,539	-619 Reduced 1.31%	46,754 $1.84 Million
Q2 2019 Jul 26, 2019	BUY	$52.76 - $82.19 $1.75 Million - $2.72 Million	33,123 Added 232.44%	47,373 $3.7 Million
Q1 2019 May 03, 2019	BUY	$27.39 - $68.41 $390,307 - $974,842	14,250 New	14,250 $850,000

153

41M

925K

617K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $290M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Aldrich Partners LLC with notifications on news.